Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]

NCT03657758 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease
Angina Pectoris

Interventions

DRUG: EPA and rosuvastatin
DRUG: High dose rosuvastatin

Sponsor

Kobe University